Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Effect of beinaglutide treatment on weight loss in Chinese patients with type 2 diabetes mellitus and overweight/obesity

Open access

Abstract

OBJECTIVE: To evaluate the effect of beinaglutide on weight loss and plasma protein patterns of inflammation/obesity relevant cytokines and biomarkers. METHODS: and T2DM. Beinaglutide was administered for three months. Changes in body weight, fasting plasma glucose (FPG) level, 2 h postprandial plasma glucose (2h-PG) level, glycosylated hemoglobin (HbA1c) level, BMI and visceral and subcutaneous fat areas were measured at baseline and after three months of treatment. In addition, relevant inflammation/obesity cytokines and biomarkers were measured. RESULTS: After three months, beinaglutide treatment led to significant changes, including in body weight, BMI, FPG level, HbA1c level, visceral and subcutaneous fat areas. In addition, serpin E1, leptin, C-reaction protein (CRP) and tumor necrosis factor-α (TNF-α) also decreased significantly. The plasma protein concentrations of CRP (Log2 transformed) were found to be positively correlated with the percentage of weight loss (R = 0.514 and p-value = 0.021). CONCLUSION: Beinaglutide treatment resulted in weight loss, plasma glucose control and anti-inflammatory effects in patients with T2DM and overweight/obesity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.20945/2359-3997000000388

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Comparison of baseline and treatment of patients receiving beinaglutide in body weight (A), body mass index (B), waist circumference (C), hip circumference (D), waist/hip rate (E), visceral fat area (F), subcutaneous fat area (G), HbA1c (H), fasting plasma glucose (I), heart rate (J), systolic blood pressure (K) and diastolic blood pressure (L). * p < 0.05; **p < 0.01; ***p < 0.001.
Figure 1 Comparison of baseline and treatment of patients receiving beinaglutide in body weight (A), body mass index (B), waist circumference (C), hip circumference (D), waist/hip rate (E), visceral fat area (F), subcutaneous fat area (G), HbA1c (H), fasting plasma glucose (I), heart rate (J), systolic blood pressure (K) and diastolic blood pressure (L). * p < 0.05; **p < 0.01; ***p < 0.001.CC BY · PubMed Central
Figure 2 Comparison of baseline and treatment of patients receiving beinaglutide in 4 inflammation/obesity related cytokines/biomarkers. (A) Serpin E1, (B) TNF-α, (C) Leptin, (D) C-reactive protein. * p < 0.05; **p < 0.01; ***p < 0.001.
Figure 2 Comparison of baseline and treatment of patients receiving beinaglutide in 4 inflammation/obesity related cytokines/biomarkers. (A) Serpin E1, (B) TNF-α, (C) Leptin, (D) C-reactive protein. * p < 0.05; **p < 0.01; ***p < 0.001.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 18

Metadata

Authors
Wang, G., Wu, P., Qiu, Y., Dong, X., Wang, Y., Chi, Y., Zhang, F., Li, Y., Zhang, J., Huang, Z., Du, X., & Du, Z.
Affiliations
Shanxi Datong University (CN)
Corresponding author
Du, Zhiqiang
Venue
Archives of Endocrinology and Metabolism
Published
2021-07-16
Volume
65
Issue
4
Pages
421-427
ISSN
  • 2359-3997 (ISSN-L)
  • 2359-4292
OpenAlex
W3185604417
Cited by
17
References
30
Citations by year
2026: 1 · 2025: 6 · 2024: 3 · 2023: 6 · 2021: 1
FWCI
1.87
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Archives of Endocrinology and Metabolism (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
Keywords
type 2 diabetes, obesity, weight loss, glycemic control, inflammation, C-reactive protein, TNF-α, leptin, SERPINE1, visceral fat, subcutaneous adipose tissue, HbA1c, Chinese patients
MeSH terms
Adult, Blood Glucose, China, Diabetes Mellitus, Type 2, Humans, Obesity, Weight Loss, Body Mass Index, Overweight

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of beinaglutide treatment on weight loss in Chinese patients with type 2 diabetes mellitus and overweight/obesity. https://app.cochat.ai/papers/10.20945/2359-3997000000388
The paper
Wang, G., Wu, P., Qiu, Y., Dong, X., Wang, Y., Chi, Y., Zhang, F., Li, Y., Zhang, J., Huang, Z., Du, X., & Du, Z. (2021). Effect of beinaglutide treatment on weight loss in Chinese patients with type 2 diabetes mellitus and overweight/obesity. Archives of Endocrinology and Metabolism. https://doi.org/10.20945/2359-3997000000388

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.